Pharmacological selectivity of SGLT2 inhibitors and cardiovascular outcomes in patients with type 2 diabetes: a meta-analysis

Authors: A A Sayour, A Olah, M Ruppert, B A Barta, K Benke, B Merkely, T Radovits

Published: 2022-10-15

DOI: 10.1093/eurheartj/ehac544.2688

Source: Full article